Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
Freifeld Y, Ghandour R, Singla N, Woldu S, Clinton T, Kulangara R, Bagrodia A, Matin SF, Petros FG, Raman JD, Robyak H, Yan J, Zhu H, Rapoport L, Lotan Y, Margulis V. Freifeld Y, et al. Among authors: petros fg. Urol Oncol. 2019 Oct;37(10):758-764. doi: 10.1016/j.urolonc.2019.06.009. Epub 2019 Aug 2. Urol Oncol. 2019. PMID: 31378586
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Foerster B, Abufaraj M, Petros F, Azizi M, Gupta M, Schweitzer D, Margulis V, Iwata T, Kimura S, Shabsigh A, Briganti A, Ku JH, Muilwijk T, Kassouf W, Matin SF, Spiess PE, Pierorazio PM, Hendricksen K, Shariat SF; UTUC Collaboration. Foerster B, et al. J Urol. 2020 Jun;203(6):1101-1108. doi: 10.1097/JU.0000000000000737. Epub 2020 Jan 2. J Urol. 2020. PMID: 31898919
Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.
Duplisea JJ, Petros FG, Li R, Fellman B, Guo CC, Czerniak BA, Siefker-Radtke AO, Araujo JC, Dinney CPN, Matin SF. Duplisea JJ, et al. Among authors: petros fg. Urol Oncol. 2019 Jun;37(6):354.e19-354.e26. doi: 10.1016/j.urolonc.2019.01.026. Epub 2019 Feb 16. Urol Oncol. 2019. PMID: 30777393 Free PMC article.
Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Singla N, Christie A, Freifeld Y, Ghandour RA, Woldu SL, Clinton TN, Petros FG, Robyak H, Yeh HC, Fang D, Enikeev D, Bagrodia A, Sagalowsky AI, Lotan Y, Raman JD, Matin SF, Margulis V. Singla N, et al. Among authors: petros fg. Urol Oncol. 2020 Dec;38(12):933.e7-933.e12. doi: 10.1016/j.urolonc.2020.04.025. Epub 2020 May 16. Urol Oncol. 2020. PMID: 32430254 Free PMC article.
Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy.
Freifeld Y, Ghandour R, Singla N, Woldu S, Bagrodia A, Lotan Y, Rapoport LM, Gazimiev M, Delafuente K, Kulangara R, Robyak H, Petros FG, Raman JD, Matin SF, Margulis V. Freifeld Y, et al. Among authors: petros fg. Urol Oncol. 2020 Sep;38(9):737.e11-737.e16. doi: 10.1016/j.urolonc.2020.05.002. Epub 2020 Jul 5. Urol Oncol. 2020. PMID: 32641241
Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.
Ghandour RA, Freifeld Y, Cheaib J, Singla N, Meng X, Kenigsberg A, Bagrodia A, Woldu S, Hoffman-Censits J, Enikeev D, Rapoport L, Petros FG, Raman JD, Pierorazio PM, Matin SF, Margulis V. Ghandour RA, et al. Among authors: petros fg. Urol Oncol. 2021 Nov;39(11):788.e15-788.e21. doi: 10.1016/j.urolonc.2021.05.037. Epub 2021 Jul 28. Urol Oncol. 2021. PMID: 34330655
52 results